AGEN Latest News

Agenus to Present First Phase 2 Botensilimab Data in Advanced Cutaneous Melanoma at ASCO 2026

businesswire.com — Apr 21, 2026

LEXINGTON, Mass. --(BUSINESS WIRE)---- $AGEN #AI--Agenus Inc.

Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs

businesswire.com — Apr 21, 2026

LEXINGTON, Mass. & MARLOW, England--(BUSINESS WIRE)---- $AGEN #AAC--Agenus Inc.

Is Agenus (AGEN) Outperforming Other Medical Stocks This Year?

zacks.com — Apr 20, 2026

Here is how Agenus (AGEN) and Apyx Medical (APYX) have performed compared to their sector so far this year.

Agenus Reports Phase II Data Demonstrating Immune Reprogramming and Durable Survival with Botensilimab, Balstilimab and agenT-797 in PD-1 Refractory Gastroesophageal Cancer

businesswire.com — Apr 17, 2026

LEXINGTON, Mass. --(BUSINESS WIRE)---- $AGEN #AACR2026--Agenus Inc.

Agenus (AGEN) is a Great Momentum Stock: Should You Buy?

zacks.com — Apr 14, 2026

Does Agenus (AGEN) have what it takes to be a top stock pick for momentum investors? Let's find out.